Russell Investments Group’s Nuvalent NUVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.48M Buy
92,502
+1,307
+1% +$133K 0.01% 975
2025
Q4
$9.17M Sell
91,195
-1,289
-1% -$127K 0.01% 967
2025
Q3
$8M Buy
92,484
+10,875
+13% +$860K 0.01% 1019
2025
Q2
$6.23M Sell
81,609
-28,747
-26% -$2.1M 0.01% 1084
2025
Q1
$7.83M Buy
110,356
+109,574
+14,012% +$8.57M 0.01% 932
2024
Q4
$61.3K Buy
782
+16
+2% +$1.49K ﹤0.01% 2780
2024
Q3
$78.5K Sell
766
-223
-23% -$18.5K ﹤0.01% 2705
2024
Q2
$75K Buy
+989
New +$70.3K ﹤0.01% 2685

Other funds holding NUVL

Russell Investments Group's NUVL Position: Q1 2026 in Review

Russell Investments Group increased its Nuvalent (NUVL) stake by 1.4% in Q1 2026, buying an estimated $133K and bringing the position to 92,502 shares worth $9.48M. The position accounts for 0.01% of the portfolio, ranked #975.

Russell Investments Group first reported a position in NUVL in Q2 2024 and has held it in 8 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Russell Investments Group held 92,502 shares of Nuvalent worth $9.48M as of Q1 2026.
  • Russell Investments Group bought 1,307 Nuvalent shares in Q1 2026, an estimated $133K.
  • Nuvalent made up 0.01% of Russell Investments Group's portfolio in Q1 2026, its #975 holding.
  • Russell Investments Group first reported a position in Nuvalent in Q2 2024 and has held it in 8 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.